| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
49,310,000 |
| Market
Cap: |
449.71(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.12 - $9.12 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Merrifield C Ann |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
14,500 |
|
- |
|
| Stejbach Mark |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
6,551 |
|
- |
|
| Mahatme Sandesh |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
4,500 |
|
- |
|
| Canute Scott A |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
4,500 |
|
- |
|
| Colella Samuel D |
Director |
– • • |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
30,004 |
|
- |
|
| Mahaffy Patrick J |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
35,324 |
|
- |
|
| Willwerth Christina |
Chief Strategy Officer |
• – – |
2020-06-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(435) |
83,038 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2020-05-26 |
4 |
B |
$9.75 |
$99,996 |
I/I |
10,256 |
346,605 |
2.66 |
5% |
|
| Stejbach Mark |
Director |
– • – |
2020-05-26 |
4 |
B |
$9.75 |
$19,997 |
D/D |
2,051 |
2,051 |
2.39 |
5% |
|
| Arkowitz David |
Chief Financial Officer |
• – – |
2020-05-07 |
4 |
AS |
$10.88 |
$26,253 |
D/D |
(2,413) |
117,068 |
|
19% |
|
| Layman Melissa |
Chief Commercial Officer |
• – – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
61,000 |
61,000 |
|
- |
|
| Wentworth Kerry |
Chief Regulatory Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
81,061 |
|
- |
|
| Arkowitz David |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
119,481 |
|
- |
|
| Willwerth Christina |
Chief Strategy Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
83,473 |
|
- |
|
| Kelley Scott |
Chief Medical Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
80,365 |
|
- |
|
| Levine Mark S. |
General Counsel |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
74,487 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2020-01-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,457 |
336,349 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2020-01-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,457 |
64,957 |
|
- |
|
| Willwerth Christina |
Chief Strategy Officer |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,533) |
52,473 |
|
59% |
|
| Bodick Neil |
Chief Scientific Officer |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,851) |
100,153 |
|
59% |
|
| Arkowitz David |
Chief Financial Officer |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,095) |
88,481 |
|
59% |
|
| Wentworth Kerry |
Chief Regulatory Officer |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,724) |
50,061 |
|
59% |
|
| Kelley Scott |
Chief Medical Officer |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,724) |
49,365 |
|
59% |
|
| Levine Mark S. |
General Counsel |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,724) |
43,487 |
|
59% |
|
| Clayman Michael D. |
President and CEO |
• • – |
2020-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,494) |
70,414 |
|
- |
|
279 Records found
|
|
Page 4 of 12 |
|
|
